Bruker Corp (BRKR) stock
BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30308% above fair value
$61.36+0.74 (+1.22%)
Close on Nov 17, 2026Market cap $9.52BP/E –Yield –
Bruker operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Bruker's operating income for the twelve months ending Jun 30, 2026 was -$30.60M, down 116.6% year over year. For fiscal 2025 it was $68.20M, down 73.1% from the year before. Over ten years it grew -7.3% a year on average. The highest annual figure on record is $436.90M in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.20M | -73.1% |
| FY2024 | Dec 31, 2024 | $253.10M | -42.1% |
| FY2023 | Dec 31, 2023 | $436.90M | +1.0% |
| FY2022 | Dec 31, 2022 | $432.70M | +4.7% |
| FY2021 | Dec 31, 2021 | $413.30M | +66.5% |
| FY2020 | Dec 31, 2020 | $248.30M | -17.5% |
| FY2019 | Dec 31, 2019 | $300.90M | +14.7% |
| FY2018 | Dec 31, 2018 | $262.40M | +19.5% |
| FY2017 | Dec 31, 2017 | $219.50M | +20.7% |
| FY2016 | Dec 31, 2016 | $181.80M | +24.8% |
| FY2015 | Dec 31, 2015 | $145.70M | +38.2% |
| FY2014 | Dec 31, 2014 | $105.40M | -28.9% |
| FY2013 | Dec 31, 2013 | $148.20M | -5.0% |
| FY2012 | Dec 31, 2012 | $156.00M | +0.3% |
| FY2011 | Dec 31, 2011 | $155.60M | -0.1% |
| FY2010 | Dec 31, 2010 | $155.70M | +13.9% |
| FY2009 | Dec 31, 2009 | $136.70M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$65.30M | -648.7% |
| Q1 FY2026 | Mar 31, 2026 | $10.20M | -67.9% |
| Q4 FY2025 | Dec 31, 2025 | $76.30M | +5.8% |
| Q3 FY2025 | Sep 30, 2025 | -$51.80M | -176.1% |
| Q2 FY2025 | Jun 30, 2025 | $11.90M | -75.3% |
| Q1 FY2025 | Mar 31, 2025 | $31.80M | -50.9% |
| Q4 FY2024 | Dec 31, 2024 | $72.10M | -30.3% |
| Q3 FY2024 | Sep 30, 2024 | $68.10M | -45.3% |
| Q2 FY2024 | Jun 30, 2024 | $48.10M | -44.2% |
| Q1 FY2024 | Mar 31, 2024 | $64.80M | -47.2% |
| Q4 FY2023 | Dec 31, 2023 | $103.50M | -21.0% |
| Q3 FY2023 | Sep 30, 2023 | $124.50M | -5.2% |
| Q2 FY2023 | Jun 30, 2023 | $86.20M | +16.6% |
| Q1 FY2023 | Mar 31, 2023 | $122.70M | +27.2% |
| Q4 FY2022 | Dec 31, 2022 | $131.00M | +4.5% |
| Q3 FY2022 | Sep 30, 2022 | $131.30M | +16.0% |
| Q2 FY2022 | Jun 30, 2022 | $73.90M | -13.7% |
| Q1 FY2022 | Mar 31, 2022 | $96.50M | +8.3% |
| Q4 FY2021 | Dec 31, 2021 | $125.40M | +11.2% |
| Q3 FY2021 | Sep 30, 2021 | $113.20M | +39.4% |
| Q2 FY2021 | Jun 30, 2021 | $85.60M | +125.9% |
| Q1 FY2021 | Mar 31, 2021 | $89.10M | +443.3% |
| Q4 FY2020 | Dec 31, 2020 | $112.80M | -4.2% |
| Q3 FY2020 | Sep 30, 2020 | $81.20M | -7.5% |
| Q2 FY2020 | Jun 30, 2020 | $37.90M | -29.2% |
| Q1 FY2020 | Mar 31, 2020 | $16.40M | -60.9% |
| Q4 FY2019 | Dec 31, 2019 | $117.70M | +10.6% |
| Q3 FY2019 | Sep 30, 2019 | $87.80M | +27.1% |
| Q2 FY2019 | Jun 30, 2019 | $53.50M | +9.6% |
| Q1 FY2019 | Mar 31, 2019 | $41.90M | +10.0% |
| Q4 FY2018 | Dec 31, 2018 | $106.40M | +11.6% |
| Q3 FY2018 | Sep 30, 2018 | $69.10M | +34.7% |
| Q2 FY2018 | Jun 30, 2018 | $48.80M | +38.2% |
| Q1 FY2018 | Mar 31, 2018 | $38.10M | +1.3% |
| Q4 FY2017 | Dec 31, 2017 | $95.30M | +23.9% |
| Q3 FY2017 | Sep 30, 2017 | $51.30M | +11.8% |
| Q2 FY2017 | Jun 30, 2017 | $35.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $37.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $76.90M | – |
| Q3 FY2016 | Sep 30, 2016 | $45.90M | – |
See a number that looks wrong?